MATERIALS BASED ON BIOGLASS 45S5, DOPED WITH HEAVY ELEMENTS, FOR USE AS RADIOSENSITIZERS

Dina N. Grishchenko – senior researcher, Candidate of Chemical Sciences, Institute of Chemistry, Far Eastern Branch of the Russian Academy of Sciences, Vladivostok, Russia
Olga S. Plotnikova – assistant, Institute of Surgery, Pacific State Medical University of the Ministry of Health of the Russian Federation, Vladivostok, Russia
Valery G. Kuryavyi – senior researcher, Candidate of Chemical Sciences, Institute of Chemistry, Far Eastern Branch of the Russian Academy of Sciences, Vladivostok, Russia
Vladimir I. Apanasevich – Doctor of Medical Sciences, Professor, Institute of Surgery, Pacific State Medical University of the Ministry of Health of the Russian Federation, Vladivostok, Russia
Michael A. Medkov – Doctor of Chemical Sciences, Professor, Institute of Chemistry, Far Eastern Branch of the Russian Academy of Sciences, Vladivostok, Russia

1. Fendler W., Tomasik B., Atkins K., et al. The clinician's guide to radiotherapy complications // Pol Arch Intern Med. 2022. V. 132, No. 1. P. 16190.
2. Moreno A. C., Frank S. J., Garden A. S., et al. Intensity modulated proton therapy (IMPT) – The future of IMRT for head and neck cancer // Oral Oncol. 2019. V. 88. P. 66 – 74.
3. Jiang S. H., Hu L. P., Wang X., et al. Neurotransmitters: emerging targets in cancer // Oncogene. 2020. V. 39, No. 3. P. 503 – 515.
4. Sun W., Chen K., Li Y., et al. Optimization of collimator angles in dual-arc volumetric modulated arc therapy planning for whole-brain radiotherapy with hippocampus and inner ear sparing // Sci Rep. 2021. V. 11. P. 19035.
5. Crezee J., Oei A. L., Franken N. A. P., et al. Response: Commentary: The impact of the time interval between radiation and hyperthermia on clinical outcome in patients with locally advanced cervical cancer // Front Oncol. 2020. V. 10. P. 528.
6. Chen S. M., Li Y. Y., Tu C. H., et al. Blockade of inhibitors of apoptosis proteins in combination with conventional chemotherapy leads to synergistic antitumor activity in medulloblastoma and cancer stem-like cells // PLoS One. 2016. V. 11, No 8. P. 0161299.
7. Tisi M., Mares V., Schreiber J., et al. Geant4 Monte Carlo simulation study of the secondary radiation fields at the laser-driven ion source LION // Sci Rep. 2021. V. 11, No 1. P. 24418.
8. Horowitz Y. S., Horowitz A., Oster L., et al. Investigation of the ionisation density dependence of the glow curve characteristics of LIF:MG, TI (TLD-100) // Radiat Prot Dosimetry. 2008. V. 131, No. 4. P. 406 – 413.
9. Медков М. А., Грищенко Д. Н., Курявый В. Г., Слободюк А. Б. Вольфрам-содержащие рентгеноконтрастные биоактивные стекла: получение и свойства // Стекло и керамика. 2018. Т. 91, № 8. С. 40 – 45.[Medkov M. A., Grishchenko D. N., Kuryavy V. G., Slobodyuk A. B. Tungsten-containing radiopaque bioactive glasses: preparation and properties // Glass Ceram. 2018. V. 75, No. 7–8. P. 322 – 326.]
10. Medkov M. A., Grishchenko D. N., Dmitrieva E. E., Kudryavyi V. G. Obtaining bioactive glasses by the pyrolysis of organic solutions // Theoretical Foundations of Chemical Engineering. 2020. V. 54, No. 4. P. 1005 – 1009.
11. Velasco M. V., Souza M. T., Crovace M. C., et al. Bioactive magnetic glass-ceramics for cancer treatment // Biomed. Glasses. 2019. V. 5, No. 1. P. 148 – 177.
12. Aspasio R. D., Borges R., Marchi J. Biocompatible glasses for cancer treatment // Marchi J. (eds) Biocompatible Glasses. Advanced Structured Materials. 2016. V. 53. P. 249 – 265.
13. Bourien H., Palard X., Rolland Y., et al. Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experience // Eur. J. Nucl. Med. Mol. Imaging. 2019. V. 46. P. 669 – 676.
14. Zhang J., Wang D., Huang W. Preparation and characterization of Fe2O3–SiO2–Y2O3–Al2O3 ferromagnetic glass ceramics microspheres for hyperthermia application // J. Chinese Ceram. Soc. 2011. V. 39, No. 6. P. 923.
15. Wang L., Long N. J., Li L., et al. Multi-functional bismuth-doped bioglasses: combining bioactivity and photothermal response for bone tumor treatment and tissue repair // Light Sci Appl. 2018. V. 7. P. 1.
16. Грищенко Д. Н., Слободюк А. Б., Курявый В. Г., Медков М. А. Танталсодержащая биоактивная стеклокерамика: механизм подавления биологической активности стекла 45S5 при его легировании Ta2O5 // Журн. неорган. химии. 2020. T. 65, № 10. С. 1408 – 1415.
17. Prasad S. S, Adarsh T., Anand A. In vitro bioactivity and antibacterial properties of bismuth oxide modified bioactive glasses // J. Mater. Res. 2018. V. 33, No. 2. P. 178 – 190.
18. Лукьяненко К. С., Апанасевич В. И., Лагурева А. В. и др. Возможность генерации вторичного ионизирующего излучения на наночастицах оксида тантала при лучевой терапии злокачественных новообразований // Тихоокеанский медицинский журнал. 2016. № 4. С. 38 – 40.
19. Пат. РФ 2794457. Способ лечения аденокарциномы Эрлиха / О. С. Плотникова, В. И. Апанасевич, М. А. Медков и др. Заявл. 20.12.2022; опубл. 18.04.2023, Бюл. № 11.
20. Nezhad Z. A., Geraily G., Hataminia F., et al. Investigation of the dose enhancement effect of spherical bismuth oxide nanoparticles in external beam radiotherapy // Nanomed Res J. 2020. V. 5, No. 1. P. 55 – 62.
21. Stewart C., Konstantinov K., McKinnon S., et al. First proof of bismuth oxide nanoparticles as efficient radiosensitisers on highly radioresistant cancer cells // Physica Medica. 2016. V. 32, No. 11. P. 1444 – 1452.
22. Wang R., Li H., Sun H. Bismuth: environmental pollution and health effects // Encyclopedia of Environmental Health (Second Edition). 2019. P. 415 – 423.
23. Rieznichenko L. S., Gruzina T. G., Dybkova S. M., et al. Investigation of bismuth nanoparticles antimicrobial activity against high pathogen microorganisms // American J Bioterror Biosecur Biodefens. 2015. V. 2, No. 1. P. 1004.
24. Alhalawani A. M., Mehrvara C., Stonec W., et al. A novel tantalum-containing bioglass. Part II. Development of a bioadhesive for sternal fixation and repair // Mater Sci Eng: C. 2017. V. 71. P. 401 – 411.